McCann FitzGerald advises Sisk on the sale of the Sisk Healthcare Group

We advised Sisk on the sale of ROI Healthco IOM 2 Limited and its subsidiaries (together the Sisk Healthcare Group) to Uniphar PLC.  The terms of the sale, which completed in August 2018 following the receipt of conditional regulatory approvals, are undisclosed.  The transaction represents an important step in the ongoing growth of the Sisk Healthcare business and reflects Uniphar's ambition to become a pan-European provider of wholesale and outsourced specialist services to the pharmaceutical and medical sectors.